{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:01:16Z","timestamp":1788868876066,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015569","name":"Canadian Consortium on Neurodegeneration in Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jamda.2019.07.025","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T08:39:21Z","timestamp":1569227961000},"page":"381-387.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Stepped-Wedge Trial"],"prefix":"10.1016","volume":"21","author":[{"given":"Julia","family":"Kirkham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Velkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2019.07.025_bib1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1041610210000608","article-title":"Prevalence of psychiatric disorders among older adults in long-term care homes: A systematic review","volume":"22","author":"Seitz","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2019.07.025_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer's disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2019.07.025_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence","volume":"293","author":"Sink","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.07.025_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0891988706292762","article-title":"Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients","volume":"20","author":"Zuidema","year":"2007","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jamda.2019.07.025_bib5","series-title":"CCSMH Guideline Update - The Assessment and Treatment of Mental Health Issues in Long-Term Care (Focus on Mood and Behaviour Symptoms)","first-page":"7","author":"Conn","year":"2014"},{"key":"10.1016\/j.jamda.2019.07.025_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0706743716673321","article-title":"Antipsychotic use in dementia: Is there a problem and are there solutions?","volume":"62","author":"Kirkham","year":"2017","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5770\/cgj.15.49","article-title":"Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)","volume":"15","author":"Gauthier","year":"2012","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.jamda.2019.07.025_bib8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2019.07.025_bib9","first-page":"CD003476","article-title":"Atypical antipsychotics for aggression and psychosis in Alzheimer's disease","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2019.07.025_bib10","series-title":"Atypical Antipsychotic Drugs and Dementia\u2014Advisories, Warnings and Recalls for Health Professionals","year":"2005"},{"key":"10.1016\/j.jamda.2019.07.025_bib11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2019.07.025_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archinte.167.7.676","article-title":"Variation in nursing home antipsychotic prescribing rates","volume":"167","author":"Rochon","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2019.07.025_bib13","series-title":"Your Health System: Potentially Inappropriate Use of Antipsychotics in Long-Term Care details for Ontario","year":"2018"},{"key":"10.1016\/j.jamda.2019.07.025_bib14","unstructured":"Centers for Medicare & Medicaid Services. National Partnership to ImproveDementia Care in Nursing Homes: Antipsychotic Medication Use Data Report (April 2019). Available at: https:\/\/www.cms.gov\/Medicare\/Provider-Enrollment-and-Certification\/SurveyCertificationGenInfo\/Downloads\/Antipsychotic-Medication-Use-Data-Report.pdf. Accessed September 4, 2019."},{"key":"10.1016\/j.jamda.2019.07.025_bib15","series-title":"The Use Of Antipsychotic Medication For People With Dementia: Time For Action","first-page":"19","author":"Banerjee","year":"2009"},{"key":"10.1016\/j.jamda.2019.07.025_bib16","first-page":"CD007726","article-title":"Withdrawal versus continuation of\u00a0chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia","author":"Declercq","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2019.07.025_bib17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamda.2014.06.012","article-title":"Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: A systematic review","volume":"15","author":"Thompson Coon","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.07.025_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/gps.4572","article-title":"Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD\u2014a factorial cluster randomised controlled trial","volume":"32","author":"Ballard","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1041610209991128","article-title":"An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: The RedUSe project","volume":"22","author":"Westbury","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2019.07.025_bib20","doi-asserted-by":"crossref","first-page":"h391","DOI":"10.1136\/bmj.h391","article-title":"The stepped wedge cluster randomised trial: Rationale, design, analysis, and reporting","volume":"350","author":"Hemming","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.jamda.2019.07.025_bib21","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"State of the Art Review: Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.jamda.2019.07.025_bib24","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z","article-title":"Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modelling","volume":"17","author":"Burton","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.jamda.2019.07.025_bib26","first-page":"35","article-title":"Antipsychotics in dementia\u2014Mortality risks and strategies to reduce prescribing","volume":"14","author":"Smith","year":"2011","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jamda.2019.07.025_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jamainternmed.2017.0746","article-title":"Association of a communication training program with use of antipsychotics in nursing homes","volume":"177","author":"Tjia","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2019.07.025_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0004867418758919","article-title":"More action needed: Psychotropic prescribing in Australian residential aged care","volume":"53","author":"Westbury","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/JGP.0b013e31817c6abe","article-title":"Psychotropic prescribing in long-term care facilities: Impact of medication reviews and educational interventions","volume":"16","author":"Nishtala","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/gps.1329","article-title":"The effect of staff training on the use of restraint in dementia: A single-blind randomised controlled trial","volume":"20","author":"Testad","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archinte.1993.00410060023005","article-title":"Reducing antipsychotic drug use in nursing homes: A controlled trial of provider education","volume":"153","author":"Ray","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2019.07.025_bib32","first-page":"833","article-title":"Effect of an interdisciplinary educational program on antipsychotic prescribing among residents with dementia in two long-term care centers","volume":"32","author":"Monette","year":"2013","journal-title":"J\u00a0Appl Gerontol"},{"key":"10.1016\/j.jamda.2019.07.025_bib33","series-title":"MDS 3.0 Quality Measures User's Manual\u2014v11.0","first-page":"34","year":"2017"},{"key":"10.1016\/j.jamda.2019.07.025_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1176\/appi.ajp.2015.15010130","article-title":"Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: A factorial cluster-randomized controlled trial by the Well-Being and Health","volume":"173","author":"Ballard","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40264-017-0554-x","article-title":"Good intentions, but what about unintended consequences?","volume":"40","author":"Kales","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.jamda.2019.07.025_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2019.07.025_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jagp.2015.07.001","article-title":"Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004-2013","volume":"23","author":"Vasudev","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.07.025_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bmjqs-2018-007840","article-title":"Public reporting of antipsychotic prescribing in nursing homes: Population-based interrupted time series analyses","volume":"28","author":"Ivers","year":"2018","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jamda.2019.07.025_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jamda.2018.05.002","article-title":"Antipsychotic deprescription for older adults in long-term care: The HALT Study","volume":"19","author":"Brodaty","year":"2018","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.07.025_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/geront\/43.2.259","article-title":"Effectiveness of continuing education\u00a0in\u00a0long-term care: A literature review","volume":"43","author":"Aylward","year":"2003","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2019.07.025_bib41","doi-asserted-by":"crossref","first-page":"897.e1","DOI":"10.1016\/j.jamda.2017.06.032","article-title":"Influences on decision-making regarding antipsychotic prescribing in nursing home residents with dementia: A systematic review and synthesis of qualitative evidence","volume":"18","author":"Walsh","year":"2017","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2019.07.025_bib42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.293.10.1239","article-title":"The unintended consequences of publicly reporting quality information","volume":"293","author":"Werner","year":"2005","journal-title":"JAMA"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019305857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019305857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:20:33Z","timestamp":1761506433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861019305857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1525861019305857"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2019.07.025","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Stepped-Wedge Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2019.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}